NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Farmland Partners Inc. (NYSE: FPI)
Class Period: May 9, 2017 - July 10, 2018
Lead Plaintiff Deadline: September 10, 2018
Join the action: http://www.zlk.com/pslra-d/farmland-partners-inc?wire=3
Allegations: Farmland Partners Inc. made materially false and/or misleading statements and/or failed to disclose that: (i)
Farmland artificially increased its revenues by marking loans to related party tenants; (ii) as a results of the foregoing,
Farmland's Class Period revenues were overstated; and (iii) as a result, Farmland's public statements were materially false and
misleading at all relevant times.
To learn more about the FPI class action contact jlevi@levikorsinsky.com.
Flex Pharma, Inc. (NASDAQ: FLKS)
Class Period: November 6, 2017 - June 12, 2018
Lead Plaintiff Deadline: August 20, 2018
Join the action: http://www.zlk.com/pslra-d/flex-pharma-inc?wire=3
Allegations: During the class period, Flex Pharma, Inc. made materially false and/or misleading statements and/or failed to
disclose that: (i) the Company overstated the viability and approval prospects for its product candidate FLX-787 for the treatment
of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and (ii) as a result, Flex's public statements were materially
false and misleading at all relevant times.
On June 13, 2018, Flex announced that it planned to halt its FLX-787 trials, citing oral tolerability concerns observed in both
studies. Flex also said that it will restructure its organization to reduce costs, including reducing its workforce by
approximately 60%, and that Flex's Board is exploring "strategic alternatives, including the potential sale or merger of the
company." Following this news, Flex stock dropped $3.14 per share, or 75.12%, to close at $1.04 on June 13, 2018.
To learn more about the FLKS class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
